Gedea Biotech has announced that Anna-Karin Areskog has been appointed QA Director.

“I am passionate about contributing to small innovative companies like Gedea with my experience. Realizing the large unmet need for Gedea’s product pHyph for relieving symptoms and preventing recurrence of bacterial vaginosis, I am so proud to be part of the development work,” says Anna-Karin Areskog.

Anna-Karin Areskog

Anna-Karin Areskog holds a master’s degree from Mälardalen University majoring on Quality in the Life Science Industry, following a degree in chemical engineering from Lund University. She has extensive experience from positions as QA/RA and Senior QA Manager within the pharmaceutical and especially medical device industries covering quality standards, regulations and guidelines such as GMP, MDR, IVDR, ISO13485 and 21 CFR 820.

Photo: Gedea Biotech